Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1140957

registered interest
date	22/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Metamizole: Side Effects
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment has been made of the side-effects of the drug metamizole.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	280288
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>Metamizole is a medicine used in some European Union countries to treat severe pain and fever. Metamizole magnesium is authorised in Spain, Portugal and Poland (as a generic medicine and under various brand names including Nolotil in Spain and Portugal and Pyralgina in Poland). The medicine has not been licensed for use in the United Kingdom.</p><p>As with all medicines, the safety of metamizole is kept under close review within the EU. A European review was conducted last year to assess all data available concerning the maximum daily dose and its contraindications on pregnancy and breastfeeding. This review was completed in December 2018 and led to agreement of harmonised information on the maximum dose to be used and that it should not be used during the third trimester of pregnancy. It was also recommended that use during breast-feeding should be avoided. As a result, consistent warnings will be available in the product information for patients and healthcare professionals within each country where authorised for use.</p><p>A recent evaluation by the European Pharmacovigilance Risk Assessment Committee noted reports of cases of agranulocytosis (lowered white blood cell count) which had occurred in UK residents in Spain. Agranulocytosis is a known risk of metamizole and is described in the product information for healthcare professionals. However, based on the review of available data, the Spanish Medicines Agency has taken further action to strengthen the warnings with regards to the risk of agranulocytosis. We are also aware that in October 2018 a communication was issued to healthcare professionals in Spain reminding them of this risk and the need to advise patients of the signs and symptoms and to avoid use in patients who have risk factors for agranulocytosis.</p><p>All medicines are supplied with information for patients which contain information on all known side effects and those signs and symptoms which they need to be aware of. Patients being treated with metamizole medicines who have any questions or concerns should talk to a healthcare professional.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 280289 280290 question first answered 25/07/2019 16:07:40 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4036 label Biography information for Luciana Berger

1140958

registered interest
date	22/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Metamizole: Spain
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will have discussions with his Spanish counterpart on the effect of dispensing metamizole to (a) UK and (b) Spanish residents in Spain.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	280289
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>Metamizole is a medicine used in some European Union countries to treat severe pain and fever. Metamizole magnesium is authorised in Spain, Portugal and Poland (as a generic medicine and under various brand names including Nolotil in Spain and Portugal and Pyralgina in Poland). The medicine has not been licensed for use in the United Kingdom.</p><p>As with all medicines, the safety of metamizole is kept under close review within the EU. A European review was conducted last year to assess all data available concerning the maximum daily dose and its contraindications on pregnancy and breastfeeding. This review was completed in December 2018 and led to agreement of harmonised information on the maximum dose to be used and that it should not be used during the third trimester of pregnancy. It was also recommended that use during breast-feeding should be avoided. As a result, consistent warnings will be available in the product information for patients and healthcare professionals within each country where authorised for use.</p><p>A recent evaluation by the European Pharmacovigilance Risk Assessment Committee noted reports of cases of agranulocytosis (lowered white blood cell count) which had occurred in UK residents in Spain. Agranulocytosis is a known risk of metamizole and is described in the product information for healthcare professionals. However, based on the review of available data, the Spanish Medicines Agency has taken further action to strengthen the warnings with regards to the risk of agranulocytosis. We are also aware that in October 2018 a communication was issued to healthcare professionals in Spain reminding them of this risk and the need to advise patients of the signs and symptoms and to avoid use in patients who have risk factors for agranulocytosis.</p><p>All medicines are supplied with information for patients which contain information on all known side effects and those signs and symptoms which they need to be aware of. Patients being treated with metamizole medicines who have any questions or concerns should talk to a healthcare professional.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 280288 280290 question first answered 25/07/2019 16:07:40 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4036 label Biography information for Luciana Berger

1140960

registered interest
date	22/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Metamizole: Spain
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps the Government is taking to raise awareness of the potential side-effects of the drug metamizole among UK citizens and tourists in Spain.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	280290
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>Metamizole is a medicine used in some European Union countries to treat severe pain and fever. Metamizole magnesium is authorised in Spain, Portugal and Poland (as a generic medicine and under various brand names including Nolotil in Spain and Portugal and Pyralgina in Poland). The medicine has not been licensed for use in the United Kingdom.</p><p>As with all medicines, the safety of metamizole is kept under close review within the EU. A European review was conducted last year to assess all data available concerning the maximum daily dose and its contraindications on pregnancy and breastfeeding. This review was completed in December 2018 and led to agreement of harmonised information on the maximum dose to be used and that it should not be used during the third trimester of pregnancy. It was also recommended that use during breast-feeding should be avoided. As a result, consistent warnings will be available in the product information for patients and healthcare professionals within each country where authorised for use.</p><p>A recent evaluation by the European Pharmacovigilance Risk Assessment Committee noted reports of cases of agranulocytosis (lowered white blood cell count) which had occurred in UK residents in Spain. Agranulocytosis is a known risk of metamizole and is described in the product information for healthcare professionals. However, based on the review of available data, the Spanish Medicines Agency has taken further action to strengthen the warnings with regards to the risk of agranulocytosis. We are also aware that in October 2018 a communication was issued to healthcare professionals in Spain reminding them of this risk and the need to advise patients of the signs and symptoms and to avoid use in patients who have risk factors for agranulocytosis.</p><p>All medicines are supplied with information for patients which contain information on all known side effects and those signs and symptoms which they need to be aware of. Patients being treated with metamizole medicines who have any questions or concerns should talk to a healthcare professional.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 280288 280289 question first answered 25/07/2019 16:07:40 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4036 label Biography information for Luciana Berger

1135177

registered interest
date	27/06/2019
answering body	Ministry of Housing, Communities and Local Government
answering dept id	7
answering dept short name	Housing, Communities and Local Government
answering dept sort name	Housing, Communities and Local Government
hansard heading	Garden Communities
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Housing, Communities and Local Government,with reference to the Loneliness Strategy, what steps he is taking to work with Homes England to incorporate community cohesion as part of the support offered to existing and future garden communities.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	270355
answer	answer is ministerial correction date of answer 02/07/2019 answer text <p>Across England, we are currently supporting 48 locally-led garden communities, to be exemplars of high quality, good design and best practice.</p><p>These places will encourage strong social connections through vibrant spaces with mixed community use and healthy places that take a holistic approach to tackling wellbeing priorities. To date we have provided £38 million in capacity funding which includes early support to fund dedicated staff teams, key studies and assessments to underpin delivery of our garden towns and villages.</p><p>My Department and Homes England are exploring an effective means of sharing learning and good practice on tackling loneliness and social isolation through design and planning approaches with professional and accredited bodies.</p> answering member constituency North West Hampshire answering member printed Kit Malthouse question first answered 02/07/2019 14:38:11 answering member 4495 label Biography information for Kit Malthouse
tabling member	4036 label Biography information for Luciana Berger

1134972

registered interest
date	26/06/2019
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Education: Judaism
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, how many (a) children and (b) schools have covered the Battle of Cable Street at Key Stage 3 in the 2018-19 academic year.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	269714
answer	answer is ministerial correction date of answer 01/07/2019 answer text <p>The information requested is not held centrally.</p><p> </p><p>The history curriculum gives teachers and schools the freedom and flexibility to use specific examples from history to teach pupils about the history of Britain and the wider world. Schools and teachers themselves can determine which examples and topics to use to stimulate and challenge pupils and reflect key points in history.</p><p> </p><p>Additionally, there is scope within the citizenship curriculum to highlight relevant key historical events. A high-quality citizenship education helps to provide pupils with knowledge, skills and understanding to prepare them to play a full and active part in society. The Department expects schools to go beyond the core knowledge set out in the shorter programmes of study to deliver other aspects of citizenship. Schools themselves are best placed to determine the most effective way of including these challenges within the school curriculum.</p> answering member constituency Bognor Regis and Littlehampton answering member printed Nick Gibb question first answered 01/07/2019 15:59:40 answering member 111 label Biography information for Nick Gibb
tabling member	4036 label Biography information for Luciana Berger

1134973

registered interest
date	26/06/2019
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Off-payroll Working
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, whether his Department plans to undertake a review of IR35 legislation ahead of the introduction of Off-Payroll tax.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	269715
answer	answer is ministerial correction date of answer 01/07/2019 answer text <p>A consultation on the detail of extending reform of the off-payroll rules closed in May and the Government will publish its response in due course. The Government is considering the responses to that consultation, which will be taken into account in the design of the draft Finance Bill legislation which will be published on 11 July.</p><p> </p><p>The off-payroll working rules (commonly known as IR35) are designed to ensure that individuals who work like employees pay broadly the same income tax and national insurance contributions (NICs) as employees, regardless of the structure they work through. The rules have been in place since 2000.</p><p> </p><p>HMRC data shows non-compliance with these rules is widespread. To address this, the Government is extending the previous reforms for the public sector to all medium and large organisations from April 2020. This reform will ensure better compliance with the rules. It does not introduce a new tax.</p><p> </p><p>HMRC have measured the impact of reforming the off-payroll rules in the public sector and estimate the reform has already raised an additional £550 million in income tax and NICs in the first 12 months since it was introduced. HMRC also published independent research into the impact of these reforms in May 2018.</p> answering member constituency Hereford and South Herefordshire answering member printed Jesse Norman question first answered 01/07/2019 16:05:58 answering member 3991 label Biography information for Jesse Norman
tabling member	4036 label Biography information for Luciana Berger

1134974

registered interest
date	26/06/2019
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Off-payroll Working
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, what steps his Department is taking to tackle stakeholders' concerns on the Check Employment Status for Tax tool ahead of the introduction of the Off-Payroll tax.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	269716
answer	answer is ministerial correction date of answer 01/07/2019 answer text <p>HMRC’s Check Employment Status for Tax (CEST) service was rigorously tested against known case law and settled cases, and HMRC stand by the result if it is used in accordance with its guidance.</p><p> </p><p>HMRC continue to enhance CEST in response to stakeholders’ concerns. Improvements will be made to language and presentation and include guidance to ensure questions are clearly understood. Changes are being tested with tax specialists and users of the service to ensure they meet individuals’ and businesses’ needs.</p> answering member constituency Hereford and South Herefordshire answering member printed Jesse Norman question first answered 01/07/2019 15:48:53 answering member 3991 label Biography information for Jesse Norman
tabling member	4036 label Biography information for Luciana Berger

1134975

registered interest
date	26/06/2019
answering body	Ministry of Housing, Communities and Local Government
answering dept id	7
answering dept short name	Housing, Communities and Local Government
answering dept sort name	Housing, Communities and Local Government
hansard heading	Garden Communities
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Housing, Communities and Local Government, what steps he is taking as part of the loneliness strategy to ensure that community cohesion is considered in the assessment process for prospective Garden Communities.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	269717
answer	answer is ministerial correction date of answer 01/07/2019 answer text <p>Prospective garden communities were required to outline how they would achieve ten design qualities in their proposals. These qualities help create places that support cohesive communities, and proposals were assessed against these criteria.</p><p>More broadly, we included tackling loneliness as a theme at our national design quality conference in February and are currently developing proposals around housing and placemaking for phase 2 of the loneliness strategy.</p> answering member constituency North West Hampshire answering member printed Kit Malthouse question first answered 01/07/2019 15:14:56 answering member 4495 label Biography information for Kit Malthouse
tabling member	4036 label Biography information for Luciana Berger

1134572

registered interest
date	25/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Genito-urinary Medicine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the announcement, Government review confirms local authorities will continue to commission public health services, published by his Department on 7 June 2019, when he plans to publish the proposals in relation to the review of the commissioning arrangements for sexual and reproductive health set out in paragraph 2.4 of the NHS Long Term Plan.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	269039
answer	answer is ministerial correction date of answer 01/07/2019 answer text <p>My Rt. hon. Friend the Secretary of State for Health and Social Care announced the outcome of the review, confirming that local authorities will continue to take the lead in commissioning sexual and reproductive health, school nursing and health visiting services, at his Royal Society of Medicine lecture on 6 June.</p><p>The review consulted a range of stake-holders. Stakeholder forums were organised by the National Aids Trust and the Public Health Systems Group, to which many organisations were invited to express their views. Officials from the Department also met with a number of organisations, and the review received a number of written submissions.</p><p>The forthcoming Prevention Green Paper will provide an opportunity for people to give us their views on more we can do to encourage local authorities and National Health Service bodies to work well together in commissioning health services.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 269040 269041 question first answered 01/07/2019 15:44:35 answering member 4455 label Biography information for Seema Kennedy
tabling member	4036 label Biography information for Luciana Berger

1134242

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Care Homes: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of care homes are rated inadequate by the Care Quality Commission in (a) Liverpool, (b) the North West and (c) England.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	268458
answer	answer is ministerial correction date of answer 27/06/2019 answer text <p>The Care Quality Commission (CQC) has provided the following data:</p><table><tbody><tr><td><p>-</p></td><td><p>Number of active care homes with latest overall rating as ‘Inadequate’</p></td><td><p>Total active care homes</p></td><td><p>Percentage<sup>1</sup> of active care homes by latest overall rating</p></td></tr><tr><td><p>Liverpool Local Authority</p></td><td><p>1</p></td><td><p>89</p></td><td><p>1.1%</p></td></tr><tr><td><p>North West Region</p></td><td><p>20</p></td><td><p>1,915</p></td><td><p>1.0%</p></td></tr><tr><td><p>England</p></td><td><p>230</p></td><td><p>15,668</p></td><td><p>1.5%</p></td></tr></tbody></table><p>Notes: <sup>1</sup>Percentages for each latest overall rating are as a proportion of total active care homes, including homes with no published rating to date.</p><p>The data provided can be used in accordance with the Open Government Licence for Public Sector Information by acknowledging the CQC as the data source.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 27/06/2019 09:57:50 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4036 label Biography information for Luciana Berger